Xiling Lin

2.8k total citations · 2 hit papers
19 papers, 1.8k citations indexed

About

Xiling Lin is a scholar working on Ophthalmology, Epidemiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Xiling Lin has authored 19 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Ophthalmology, 5 papers in Epidemiology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Xiling Lin's work include Retinal Diseases and Treatments (6 papers), Retinal Imaging and Analysis (5 papers) and Global Public Health Policies and Epidemiology (5 papers). Xiling Lin is often cited by papers focused on Retinal Diseases and Treatments (6 papers), Retinal Imaging and Analysis (5 papers) and Global Public Health Policies and Epidemiology (5 papers). Xiling Lin collaborates with scholars based in China and Russia. Xiling Lin's co-authors include Xiaowen Pan, Jingya Xu, Yuezhong Ren, Yufeng Xu, Xue Sun, Yue Ding, Xiaoxiao Song, Peng‐Fei Shan, Junyun Wu and Xin Huang and has published in prestigious journals such as Scientific Reports, Public Health Nutrition and Experimental Eye Research.

In The Last Decade

Xiling Lin

17 papers receiving 1.8k citations

Hit Papers

Global, regional, and national burden and trend of diabet... 2020 2026 2022 2024 2020 2022 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025
    2020 1.2k citations Xiling Lin, Yufeng Xu et al. Scientific Reports profile →
  2. The Global Burden of Osteoporosis, Low Bone Mass, and Its Related Fracture in 204 Countries and Territories, 1990-2019
    2022 214 citations Xin Huang, Junyun Wu et al. Frontiers in Endocrinology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiling Lin China 12 559 320 287 227 218 19 1.8k
Xiaowen Pan China 11 570 1.0× 340 1.1× 269 0.9× 246 1.1× 202 0.9× 14 1.7k
Jingya Xu China 15 562 1.0× 425 1.3× 273 1.0× 247 1.1× 190 0.9× 33 1.9k
Ozra Tabatabaei‐Malazy Iran 25 672 1.2× 471 1.5× 299 1.0× 368 1.6× 154 0.7× 125 1.9k
Yuezhong Ren China 17 641 1.1× 611 1.9× 371 1.3× 378 1.7× 271 1.2× 38 2.4k
Seung‐Won Oh South Korea 21 393 0.7× 183 0.6× 423 1.5× 338 1.5× 190 0.9× 96 1.8k
Tiansheng Wang United States 27 721 1.3× 389 1.2× 235 0.8× 235 1.0× 355 1.6× 96 2.0k
Rakesh Sahay India 28 1.4k 2.5× 369 1.2× 336 1.2× 407 1.8× 352 1.6× 230 2.9k
Jinhee Lee South Korea 20 507 0.9× 243 0.8× 326 1.1× 181 0.8× 161 0.7× 56 1.6k
Moonsuk Nam South Korea 23 510 0.9× 452 1.4× 328 1.1× 226 1.0× 193 0.9× 71 1.4k

Countries citing papers authored by Xiling Lin

Since Specialization
Citations

This map shows the geographic impact of Xiling Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiling Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiling Lin more than expected).

Fields of papers citing papers by Xiling Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiling Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiling Lin. The network helps show where Xiling Lin may publish in the future.

Co-authorship network of co-authors of Xiling Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Xiling Lin. A scholar is included among the top collaborators of Xiling Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiling Lin. Xiling Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
3.
4.
Pan, Xiaowen, Xiling Lin, Xin Huang, et al.. (2022). The Burden of Diabetes-Related Chronic Kidney Disease in China From 1990 to 2019. Frontiers in Endocrinology. 13. 892860–892860. 33 indexed citations
5.
Huang, Xin, Junyun Wu, Xiling Lin, et al.. (2022). The Global Burden of Osteoporosis, Low Bone Mass, and Its Related Fracture in 204 Countries and Territories, 1990-2019. Frontiers in Endocrinology. 13. 882241–882241. 214 indexed citations breakdown →
6.
Lin, Xiling, Yiwen Wu, Xin Huang, et al.. (2021). Global burden of non‐communicable diseases attributable to dietary risks in 1990–2019. Journal of Human Nutrition and Dietetics. 35(1). 202–213. 79 indexed citations
7.
Huang, Chunli, Wei‐Hua Huang, Xinghong Zhang, et al.. (2021). Identifying the impact of the Zone Insertion MethodTM (ZIMTM): A randomized controlled trial. The Journal of Vascular Access. 24(4). 729–738. 7 indexed citations
8.
Xu, Yufeng, Yi Shan, Xiling Lin, et al.. (2021). Global patterns in vision loss burden due to vitamin A deficiency from 1990 to 2017. Public Health Nutrition. 24(17). 5786–5794. 30 indexed citations
9.
Xu, Jingya, Xiling Lin, Yufeng Xu, et al.. (2021). Age, Gender and Geographic Differences in Global Health Burden of Cirrhosis and Liver Cancer due to Nonalcoholic Steatohepatitis. Journal of Cancer. 12(10). 2855–2865. 14 indexed citations
10.
Shan, Yi, Yufeng Xu, Xiling Lin, et al.. (2021). Socioeconomic disparity in global vision loss burden due to diabetic retinopathy: an analysis on time trends from 1990 to 2017. Endocrine. 73(2). 316–324. 2 indexed citations
11.
Wang, Yijie, et al.. (2020). The prognostic landscape of adaptive immune resistance signatures and infiltrating immune cells in the tumor microenvironment of uveal melanoma. Experimental Eye Research. 196. 108069–108069. 30 indexed citations
12.
Xu, Yufeng, Aihong Wang, Xiling Lin, et al.. (2020). Global burden and gender disparity of vision loss associated with diabetes retinopathy. Acta Ophthalmologica. 99(4). 431–440. 24 indexed citations
13.
Lin, Xiling, Yufeng Xu, Jingya Xu, et al.. (2020). Global burden of noncommunicable disease attributable to high body mass index in 195 countries and territories, 1990–2017. Endocrine. 69(2). 310–320. 56 indexed citations
14.
Lin, Xiling, Yufeng Xu, Xiaowen Pan, et al.. (2020). Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025. Scientific Reports. 10(1). 1205 indexed citations breakdown →
15.
Lin, Xiling, Lixia Lou, Qi Miao, et al.. (2020). The pattern and gender disparity in global burden of age-related macular degeneration. European Journal of Ophthalmology. 31(3). 1161–1170. 25 indexed citations
16.
Xu, Jingya, et al.. (2020). Global burden of noncommunicable diseases attributable to high fasting plasma glucose. Journal of Diabetes. 12(11). 807–818. 16 indexed citations
17.
Shan, Yi, Yufeng Xu, Yuexin Lu, et al.. (2020). Epidemiology and Survival Outcomes for Eyelid Primary Malignant Melanoma: An Analysis of 1397 Cases in the SEER Database. Journal of Ophthalmology. 2020. 1–9. 11 indexed citations
18.
Shan, Yi, Yufeng Xu, Xiling Lin, et al.. (2020). Burden of vision loss due to diabetic retinopathy in China from 1990 to 2017: findings from the global burden of disease study. Acta Ophthalmologica. 99(2). e267–e273. 6 indexed citations
19.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaowen Pan Breakdown of academic impact, for papers by Jingya Xu Breakdown of academic impact, for papers by Ozra Tabatabaei‐Malazy Breakdown of academic impact, for papers by Yuezhong Ren Breakdown of academic impact, for papers by Seung‐Won Oh Breakdown of academic impact, for papers by Tiansheng Wang Breakdown of academic impact, for papers by Rakesh Sahay Breakdown of academic impact, for papers by Jinhee Lee Breakdown of academic impact, for papers by Moonsuk Nam
Rankless by CCL
2026